Nasdaq Most Active

Prism Marketview
  • Home
  • Indexes
    • All Indexes
    • Aerospace and Defense
    • AI Datacenter and Infrastructure
    • Biotech
    • Cannabis
    • Comms and Media
    • Consumer Products
    • Cybersecurity
    • Crypto Mining
    • EV
    • Fintech
    • Global Health
    • Healthcare
    • MedDevices
    • Mental Health
    • New Energy
    • NextGen Tech & AI
    • Oil & Gas
    • Pet Care
    • Pharmaceuticals
    • Precious Metals
    • Psychedelics
    • Semiconductors
    • Space
    • Sports
    • Weight Loss
    • Wellness
    • Women?s Health
  • Companies
  • Trending News
    • PRISM View
    • Biotech
    • Finance
    • Healthcare
    • Technology
    • Login
    • User Profile
    • Log Out
  • Home
  • Indexes
    • All Indexes
    • Aerospace and Defense
    • AI Datacenter and Infrastructure
    • Biotech
    • Cannabis
    • Comms and Media
    • Consumer Products
    • Cybersecurity
    • Crypto Mining
    • EV
    • Fintech
    • Global Health
    • Healthcare
    • MedDevices
    • Mental Health
    • New Energy
    • NextGen Tech & AI
    • Oil & Gas
    • Pet Care
    • Pharmaceuticals
    • Precious Metals
    • Psychedelics
    • Semiconductors
    • Space
    • Sports
    • Weight Loss
    • Wellness
    • Women?s Health
  • Companies
  • Trending News
    • PRISM View
    • Biotech
    • Finance
    • Healthcare
    • Technology
    • Login
    • User Profile
    • Log Out

Home medtech Page 3

Tag: medtech

Investor monitors multiple stock charts as Aethlon Medical and Surf Air Mobility lead PRISM Mid-Day Movers in MedTech and Aerospace & Defense.
September 17, 2026

PRISM Mid-Day Movers: MedTech and Aerospace & Defense are Today’s leaders.

Aethlon Medical, Inc. (NASDAQ: AEMD) surged up 383.22% to $6.91 in exceptionally active trading, with roughly 80.0 million shares changing hands versus average daily volume…

Patient undergoes transcranial magnetic stimulation treatment using a medical device, representing robotic TMS technology for psychiatric care.
September 11, 2026

NRx’s HOPE Therapeutics Prepares First Robotic TMS Deployment in Florida

Key Points NRx Pharmaceuticals’ HOPE Therapeutics subsidiary is preparing to deploy Zeta Surgical’s FDA-cleared robotic transcranial magnetic stimulation, or TMS, system in Florida clinics. HOPE…

Model of a human brain beside wooden TMS blocks, representing BrainsWay’s Deep TMS research in patients with depression and early-stage Alzheimer’s disease.
September 08, 2026

BrainsWay Pilot Study Links Deep TMS to Depression Improvement in Early Alzheimer’s Patients

Key Points BrainsWay reported results from a 12-patient pilot study of Deep TMS in people with major depressive disorder and early-stage Alzheimer’s disease. After 36…

Investor monitoring stock charts on a laptop, representing active midday trading and sharp moves across MedTech and new energy stocks.
September 02, 2026

PRISM Mid-Day Movers: MedTech and New Energy are Today’s Leaders

bioAffinity Technologies (NASDAQ: BIAF) is up sharply again today, gaining roughly 56% intraday, following yesterday’s ~46% surge tied to news that CyPath® Lung will be…

September 01, 2026

Intelligent Bio Solutions Surges Nearly 29% as Drug Screening System Hits 98.2% Accuracy, Completing FDA 510(k) Data Package

Intelligent Bio Solutions Inc. (NASDAQ: INBS), a medical technology company delivering rapid, non-invasive testing solutions, announced results on September 1, 2026 from its latest Method…

Investor analyzes stock-market charts across multiple computer screens, representing heavy trading activity and volatility among PRISM Mid-Day Movers.
September 01, 2026

PRISM Mid-Day Movers: Consumer Products and MedTech are Today’s Leaders.

GoPro (GPRO) is surging today, up roughly 44% as a wave of investor interest follows disclosure that YouTube creator Mark Fischbach—known as Markiplier—built an 8.5%…

Business professionals gather near a digital market-data display, representing active stock trading as MedTech and pharmaceutical companies lead PRISM’s mid-day movers.
August 28, 2026

PRISM Mid-Day Movers: MedTech and Pharmaceuticals are Today’s Leaders.

Aethlon Medical (AEMD) is up 23.96% today to 2.69 from Thursday’s 2.17 close, although it has retreated from an intraday high of 3.29 after opening…

Business executive holds a money bag above a group of wooden figures, representing Biomerica’s $2.23 million financing and ongoing review of strategic alternatives.
August 27, 2026

Biomerica Secures $2.23 Million and Launches Strategic Review to Unlock Shareholder Value

Key Points Biomerica agreed to sell 1,393,705 unregistered common shares at $1.60 per share, generating approximately $2.23 million in gross proceeds. The financing includes no…

Medical cannabis flower beside a prescription-style container, representing Aurora Cannabis’ expansion of its U.K. medical cannabis distribution network.
August 19, 2026

Aurora Cannabis Expands U.K. Medical Cannabis Distribution With £2.1 Million Deal

Key Points Aurora acquired 100% of Internode Pharma and HAP Pharma through a wholly owned subsidiary. The company paid £2.1 million in cash at closing,…

Investor monitoring multiple stock-market charts on computer screens, representing strong mid-day trading activity in pharmaceutical and MedTech stocks including Amylyx Pharmaceuticals and bioAffinity Technologies.
August 18, 2026

PRISM Mid-Day Movers: Pharmaceuticals and MedTech are Today’s Leaders.

Amylyx Pharmaceuticals (NASDAQ: AMLX) is rallying sharply today, up 49.42% to 32.02 from Monday’s 21.43 close after opening at 29.93. Shares have traded from 28.00…

Advanced neuroscience laboratory with brain scans displayed on monitors, representing Alzamend Neuro’s AL001 lithium brain-imaging research using high-field MRI technology.
August 18, 2026

Alzamend Neuro’s AL001 Brain-Imaging Research Takes the Stage at ISMRM

Key Points AL001 data will be presented during a 10-minute oral session on September 29, 2026, at the ISMRM X-Nuclei MR Workshop. The completed Phase…

Close-up of the U.S. Food and Drug Administration website, representing InspireMD’s upcoming FDA regulatory decisions for its CGuard carotid-stent systems.
August 18, 2026

InspireMD Targets Q4 FDA Decisions While Cutting $9 Million in Annual Costs

Key Points InspireMD expects potential FDA decisions in Q4 2026 for the CGuard Prime 80 cmsystem for transcarotid artery revascularization, or TCAR, and its original CGuard carotid artery…

Posts pagination

Previous page Page 1 Page 2 Page 3 Page 4 … Page 6 Next page

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup

News

  • Latest
  • PRISM View
  • Biotech
  • Finance
  • Healthcare
  • Technology

Indexes

  • Aerospace & Defense
  • AI Datacenter and Infrastructure
  • Biotech
  • Cannabis
  • Comms and Media
  • Consumer Products
  • Crypto Mining
  • Cybersecurity
  • EV
  • Fintech
  • Global Health
  • Healthcare
  • MedDevices
  • Mental Health
  • New Energy
  • NextGen Tech & AI
  • Oil & Gas
  • Pet Care
  • Pharmaceuticals
  • Psychedelics
  • Semiconductors
  • Space
  • Sports
  • Weight Loss
  • Wellness
  • Women’s Health
  • Home
  • About Us
  • Contact Us

Copyright © 2026 PRISM MarketView. All rights reserved.

  • Terms & Conditions
  • Privacy Policy
  • Disclaimer